IL2 and ovarian carcinoma: Vlad AM, Budiu RA, Lenzner DE, Wang Y, Thaller JA, Colonello K, Crowley-Nowick PA, Kelley JL, Price FV, Edwards RP: A phase ii trial of intraperitoneal interleukin- 2 in patients with platinum-resistant or platinum-refractory ovarian cancer.